来自Pseudomonas sp.的II型L-阿斯巴拉金酶的分泌表达和优化 在PCH199199中使用
Subhash Kumar1, Virender Kumar2, Dharam Singh3
1Molecular and Microbial Genetics Lab, CSIR-Institute of Himalayan Bioresource Technology, Palampur 176 061, Himachal Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201 002, India; Department of Bio Medical Sciences, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu 632 014, India.
概括
这项研究通过使用分泌表达系统来增强大肠杆菌中的L-阿斯巴拉金酶II (Pg-ASNase II) 生产. 优化的方法增加了细胞外酶产量,降低了治疗应用的下游加工成本.
科学领域:
- 生物技术是生物技术.
- 酶工程是什么? 酶工程是什么?
- 分子生物学分子生物学
背景情况:
- 再组合L-阿斯巴拉基酶 (L-ASNase) 对于治疗急性淋巴细胞白血病和减少食品中的烯胺至关重要.
- 目前L-ASNase的生产方法通常涉及大肠杆菌的细胞质表达,需要复杂的净化.
研究的目的:
- 开发一种高效的分泌表达系统,用于E. coli中的重组L-asparaginase II (Pg-ASNase II).
- 为了增强Pg-ASNase II的细胞外生产,用于潜在的治疗应用.
主要方法:
- 经过工程设计的大肠杆菌带有pelB信号,用于Pg-ASNase II的周等离子体表达.
- 优化培养条件,包括添加Tween 80,以增强蛋白质分泌.
- 使用单阶段的Q-色色谱,净化Pg-ASNase II.
主要成果:
- 成功地实现了Pg-ASNase II的分泌表达和分泌到大肠杆菌超体中.
- 通过将介质成分优化为0.2%的Tween 80,使蛋白质分泌量从0.33升至0.77毫克/毫升.
- 获得了8.0 mg/L的净化蛋白质,活性为60.0 U/mg,产量为75%,净化增加了15倍.
结论:
- 与原生水平相比,开发的分泌表达系统显著增强了细胞外Pg-ASNase II的产生.
- 这种方法降低了下游加工成本,并有助于周等离子体Pg-ASNase II的潜在治疗用途.
相关概念视频
Stringent Response in E. coli
533
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
533
Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99


